Tag: CLF UWS USA NAM GMY WEU EUR

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohortsDarovasertib has received U.S. FDA Breakthrough Therapy Designation...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsCLF UWS USA NAM GMY WEU EUR

Kingworld Medicines Group (01110.HK) Signs MOU to Pursue Exclusive Distribution Rights for Two Lingnan Formula Products

Banqup Group Announces Strategic Simplification Plan and Launch of Process to Explore Strategic Alternatives

We Mean Business Coalition: New polling shows overwhelming global business support for clean electrification amid fossil fuel volatility

Tag: CLF UWS USA NAM GMY WEU EUR

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us